|
3C Oncology (First-Time Presenter)
Irvine, CA | Website
3C Oncology is developing four products enhancing focally delivered radiation and drug therapies for patients with spinal metastatic disease. |
Aardvark Medical, LLC
Ross, CA | Website
Aardvark Medical has developed a novel, proprietary platform for nasal and sinus care. Aardvark plans to market professional and OTC healthcare devices that diagnose and treat patients with nasal dysfunction.” |
ActiveO, LLC (First-Time Presenter)
Incline Village, NV | Website Spine technology company focused on the development and delivery of minimally invasive, image-guided therapies to treat back pain. |
Apieron (First-Time Presenter)
Menlo Park, CA | Apieron is a privately-held medical device company with a proprietary device on the market which measures exhaled nitric oxide to determine asthma severity. |
Applied Spine Technologies, Inc.
New Haven, CT | Website Applied Spine Technologies, Inc. is developing the Stabilimax NZ®, a posterior dynamic stabilization device designed to support an injured or degenerated spine without eliminating motion. |
Aura Medsystems, Inc.
New York, NY | Aura Medsystems is a premier medical device company committed to advancing patient care by focusing on the commercialization of a novel tissue repair platform that obviates the need for sutures, stapes, glues, or other foreign bodies and instead allows the body to repair and heal itself. |
Avita Medical Ltd. (First-Time Presenter)
Cambridge, United Kingdom | Website Avita has recently introduced ReCell® Spray-On Skin, rapid, autologous cell harvesting, processing and delivery technology, accelerating healing, minimizing rejection, eliminating scar formation and reintroducing normal pigmentation, vascularisation and innervation in the treated wound area; addresses needs of the burns, wound care, plastics, dermatological and aesthetic markets. |
Bioheart, Inc.
Sunrise, FL | Website We are committed to delivering intelligent devices and biologics that monitor, diagnose and treat heart failure and cardiovascular diseases. |
Bioscan Technologies, Ltd. (First-Time Presenter)
Yokneam, Israel
| Website Bioscan Technologies has developed a novel guidewire-based intravascular ultrasound system (the LightWire™ and ArteroScan™) for use by interventional cardiologists in determining correct stent size on-line during the PCI procedure. |
Biotectix LLC (First-Time Presenter)
Ann Arbor, MI | Website Biotectix conducting polymer biomaterials are the catalyst for the next generation of implanted medical device permitting miniaturization, leapfrog gains in device performance, safety, and energy-efficiency, MRI compatibility and reduced device invasiveness.
|
Breast Cancer Initiatives (First-Time Presenter)
Charleston, SC | Website
Early stage medical device company with patent pending transformative technologies for breast cancer detection and treatment. |
Calibra Medical Inc. (First-Time Presenter)
Redwood City, CA | Develops a small, wearable, all-mechanical insulin delivery device containing a 3-day supply of insulin that can be actuated through clothing, allowing simple, discreet insulin administration without the need for complicated, programmable pumps.
|
CardioPolymers, Inc. (First-Time Presenter)
Laguna Hills, CA | Website CardioPolymers, Inc., has developed Algisyl-LVR® a novel biopolymer implant technology intended to prevent or reverse the progression of congestive heart failure in ischemic or idiopathic dilated cardiomyopathy patients. Algisyl-LVR is classified as a medical device. |
CerMed Corporation (First-Time Presenter)
Monterey, CA | Website A women’s medical device company with license and multiple internally developed products resulting in immediate revenue featuring unique point of care Paps replacement. |
CoaguSense, Inc. (First-Time Presenter)
Fremont, CA | Website CoaguSense is launching a hand-held point-of-care/home testing coagulation PT/INR monitoring system. |
CorInnova, Inc. (First-Time Presenter)
College Station, TX | Website Minimally invasive direct cardiac compression device that passively and actively controls the heart’s motion throughout the cardiac cycle. |
CVAC Systems, Inc.
Temecula, CA | Website A new, noninvasive modality to treat diabetic neuropathy—a potential $12 billion annual U.S. market |
CytoLogic Inc. (First-Time Presenter)
Aurora, CO | CytoLogic is pursuing the development and commercialization of a novel cancer immunotherapy device, which selectively removes specific blood-borne inhibitors of the immune system. |
DiFUSION Technologies (First-Time Presenter)
Austin, TX | Website Company Description Coming Soon. |
ECI Biotech
Worcester, MA | Website ECI Biotech, Inc. (ECI) is a premier developer and manufacturer of innovative, patented ExpressDetect® Diagnostics products for rapid infection determination for professional as well as consumer markets. |
Endoscape, Inc. (First-Time Presenter)
Sunnyvale, CA | Website Endoscape develops low cost disposable devices for solving the colonoscopy pain, efficiency problems and potentially, the colon preparation difficulty. An initial product is close to 510(k) submission and release. |
Epicardial Technologies, Inc. (First-Time Presenter)
San Clemente, CA | Website Epicardial Technologies: Pioneering electrophysiology products for epicardial access, visualization and treatment of arrhythmias for large, growing patient population with IP licensed from major universities. |
First Light Biosciences (First-Time Presenter)
Bedford, MA | Website
First Light is developing rapid, sensitive, and cost-effective diagnostic products for detecting microbes causing hospital associated infections. Advantages include proprietary imaging technology that counts cells and molecules without magnification, walk-away automation, and easy-to-use consumables. |
Graft-Loc
Englewood, CA | Website
Graft-Loc is a debt-free, early stage device company focused on vascular connections for use in CABG & vascular surgeries. Graft-Loc's patented device creates a reliable anastomosis to any graft site. |
Gynesonics (First-Time Presenter)
Redwood City, CA | Website
Gynesonics has developed a novel ultrasound guided ablation device to treat symptomatic uterine fibroids through a transcervical approach. |
Insituvue Inc. (First-Time Presenter)
Irvine, CA | Hand held Ultrasound device.
|
Interface Biologics (First-Time Presenter)
Toronto, Canada | Website Develops biomedical polymer technologies that enhance the safety and effectiveness of implantable medical devices by reducing thrombosis, inhibiting infection and providing effective drug delivery. |
Intrapartum LLC (First-Time Presenter)
Jacksonville, FL | Website Developed technology which enables an individual to determine with specificity the dilation of a female's cervix during labor by using a disposable glove with embedded sensors which are attached to an external read-out. |
Kerecis Limited (First-Time Presenter)
Reykjavik, Iceland
| Website Kerecis develops and manufactures tissue repair products for use in a range of reconstructive and orthopedic surgical procedures. The Kerecis technology is based on proprietary marine derived proteins. |
Micro-Imaging Solutions (First-Time Presenter)
Englewood, CO | Website Protected technology related to the development and utilization of miniature, high-resolution, low cost CMOS image sensors developed primarily for use in disposable endoscopic surgical applications. |
MicroPhage, Inc. (First-Time Presenter)
Longmont, CO | Website
Bacteriophage enabling technology that offers the ability to increase specificity and decrease time to results on existing immunodiagnostic platforms.” |
Miracor Medical Systems GmbH (First-Time Presenter)
Vienna, Austria | Website Miracor is founded to develop and commercialize the PICSO™ (Pressure-controlled Intermittent Coronary Sinus Occlusion) technology for acute coronary syndrome (ACS) and heart failure patients. The company holds an extensive patent portfolio and will start its commercialization in Europe. |
Nanospectra Biosciences, Inc.
Houston, TX | Website Engaged in the commercialization of AuroLase™ Therapy, a particle-based therapy for the precise thermal destruction of solid tumors. |
NeoMatrix, LLC (First-Time Presenter)
Irvine, CA | Website Develops innovative devices that promote optimal breast health. |
NeoVista, Inc
Fremont, CA | Website NeoVista, Inc. has a minimally invasive surgical technology that uses ionizing radiation to treat Age-Related Macular Degeneration (ARMD). |
Ortho Ion (First-Time Presenter)
Migdal HaEmek, Israel | Ortho Ion has patented a single use, disposable silver ion delivery device to treat Osteomyelitis. The company believes its novel treatment is more effective than current medical therapy, can cut cost by 80% and meets a $4B market opportunity. |
Orthopedic Sciences, Inc. (First-Time Presenter)
Seal Beach, CA | Website Later stage company designs, develops and manufactures proprietary medical products for the orthopaedic industry, specifically, musculoskeletal joint preservation and hip arthroscopy. |
OrthoX, LLC (First-Time Presenter)
Granger, IN | Website
OrthoX is commercializing a high fatigue fiber reinforced bone cement for orthopedic joint replacement.
|
Perfint Healthcare Ltd. (First-Time Presenter)
Chennai, India
| Website Perfint Healthcare, is based in Chennai, India. Launched PIGA CT - A Robotic Assistance device for CT guided interventions of Thorax/Abdomen/Pelvis in Mar ’09. Has since shipped 25 units to top hospitals in India. Raising $8-10M Series B. Current investors : IDG/Accel. |
Pico-Tesla Magnetic Therapies, LLC
Littleton, CO | Website
Later-stage, web-enabled, non invasive, neuromodulation platform technology company, beginning a phase III Clinical trial (2009) involving Parkinson’s Disease. |
Q-Core Ltd. (First-Time Presenter)
Petach Tikva, Israel | Website Research, Development, Manufacture and INNOVATION of infusion pump platforms for today and tomorrow’s electronic drug delivery needs.
|
Regenesis Biomedical, Inc. (First-Time Presenter)
Scottsdale, AZ | Website Marketing a device, Provant®, based on pulsed RF energy to trigger tissue regeneration-repair of soft tissues, including skin. |
Retina Implant AG
Reutlingen, Germany
| Website Retina Implant plans to deliver the first implanted electronic subretinal device, to give back to visually blinds parts of lost sight |
S.E.A. Medical Systems, Inc
Sunnyvale, CA | Website
Smart IVÔ is the first product to instantaneously report drug and concentration in IV lines alerting healthcare providers to errors which injure or kill hundreds of thousands of patients per year. With billions of IVs administered, the market is huge. |
Silere Medical Technology, Inc.
Kirkland, WA | Website Developing its ‘T-Stim’ platform, with the objective to design, manufacture, and bring to market electrical neural stimulators to treat hearing, balance and perceptual disorders. |
Softscope Medical Technologies
Minnetonka, MN | Website Innovative endoscopic assist device designed to significantly improve flexible endoscopy procedures. |
SquareOne, Inc. (First-Time Presenter)
Mountain View, CA | SquareOne is commercializing a highly differentiated aorto-ostial stent and delivery platform with strong IP for both peripheral and coronary application. |
Stellarray, Inc. (First-Time Presenter)
Austin, CA | Website
Stellarray makes and sells flat panel and custom radiation sources that solve problems in sterilization and medical imaging. |
Sunshine Heart Inc.
Tustin, CA | Website Cardiac assist device to treat patients in moderate to severe long term heart failure. |
Vascular Designs, Inc.
San Jose, CA | Website Catheter for the treatment of non-responsive and unresectable stage IV metastatic colorectal cancer. |